Mgc Pharmaceuticals Ltd. (AU:RGT) has released an update.

Argent BioPharma Ltd., a company at the forefront of drug discovery and development in the biopharmaceutical sector, has recently announced the appointment of Dr. Shlomo Sadoun to its advisory board. Dr. Sadoun, with over 18 years of experience and a track record of global product launches and technological innovations in the pharmaceutical industry, is expected to provide strategic insights and guidance to Argent BioPharma. The company is poised to leverage Dr. Sadoun’s expertise to drive innovation and growth as it pursues new strategic directions in the industry.

For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.


Comments are closed.